Scarica l'app Stockscreener
1.91
2.05%
-0.04
Dopo l'orario di chiusura:
1.91
Precedente Chiudi:
$1.95
Aprire:
$1.94
Volume 24 ore:
129.94K
Relative Volume:
0.29
Capitalizzazione di mercato:
$241.24M
Reddito:
-
Utile/perdita netta:
$-70.78M
Rapporto P/E:
-3.4107
EPS:
-0.56
Flusso di cassa netto:
$-61.27M
1 W Prestazione:
-3.54%
1M Prestazione:
-3.54%
6M Prestazione:
+143.93%
1 anno Prestazione:
+13.02%
Intervallo 1D:
$1.90
$1.99
Intervallo di 1 settimana:
$1.885
$2.047
Portata 52W:
$0.62
$2.54
Nautilus Biotechnology Inc Stock (NAUT) Company Profile
Nome
Nautilus Biotechnology Inc
Settore
Industria
Telefono
206-333-2001
Indirizzo
2701 EASTLAKE AVE EAST, SEATTLE
Confronta NAUT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NAUT
Nautilus Biotechnology Inc
|
1.91 | 246.29M | 0 | -70.78M | -61.27M | -0.56 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.13 | 115.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.31 | 81.12B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.17 | 52.54B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
839.99 | 51.78B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.12 | 37.12B | 447.02M | -1.18B | -906.14M | -6.1812 |
Nautilus Biotechnology Inc Stock (NAUT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-05 | Downgrade | Goldman | Neutral → Sell |
| 2024-06-27 | Iniziato | Guggenheim | Buy |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2022-01-06 | Iniziato | Morgan Stanley | Equal-Weight |
| 2021-11-02 | Iniziato | Cowen | Outperform |
| 2021-08-04 | Iniziato | Goldman | Neutral |
| 2021-07-13 | Iniziato | Jefferies | Buy |
Mostra tutto
Nautilus Biotechnology Inc Borsa (NAUT) Ultime notizie
Corient Private Wealth LLC Acquires 390,000 Shares of Nautilus Biotechnology, Inc. $NAUT - Defense World
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) boasts of bullish insider sentiment with 33% ownership and they have been buying lately - Yahoo Finance
Nautilus Biotechnology Faces Nasdaq Delisting Risk Amid Compliance Challenges - MSN
Aug Fed Impact: Is Nautilus Biotechnology Inc stock attractive for income investorsJuly 2025 PostEarnings & Fast Gain Swing Trade Alerts - moha.gov.vn
How buybacks impact Nautilus Biotechnology Inc. stock valueJuly 2025 Trends & Verified Swing Trading Watchlists - Улправда
Will Nautilus Biotechnology Inc. stock attract more institutional investors - Улправда
Published on: 2025-12-20 14:57:12 - moha.gov.vn
Why Nautilus Biotechnology Inc. stock remains on buy lists2025 Market WrapUp & Community Consensus Picks - bolumsonucanavari.com
Is Nautilus Biotechnology Inc. stock a safe buy before earnings2025 Analyst Calls & Long-Term Growth Stock Strategies - DonanımHaber
ETF Watch: Is Nautilus Biotechnology Inc. stock a safe buy before earningsJuly 2025 Retail & Step-by-Step Trade Execution Guides - DonanımHaber
Is Nautilus Biotechnology Inc. stock supported by strong fundamentalsJuly 2025 Highlights & Verified Swing Trading Watchlist - Улправда
Is Nautilus Biotechnology Inc. stock a buy before product launches2025 Volatility Report & Capital Efficiency Focused Ideas - Улправда
EPS Watch: Will Nautilus Biotechnology Inc. stock outperform tech sector in 20252025 Fundamental Recap & Safe Entry Zone Tips - Улправда
Nautilus Biotechnology Earnings Notes - Trefis
Nautilus Biotechnology drives innovation in proteomics space - Traders Union
Nautilus Biotechnology (NAUT) Stock Analysis Report | Financials & Insights - Benzinga
Nautilus Biotechnology: Divergent Signals from Investors and Analysts - AD HOC NEWS
Nautilus Biotechnology (NASDAQ:NAUT) Stock Price Up 0.5%Here's What Happened - MarketBeat
Nautilus Biotechnology (NASDAQ:NAUT) Stock Price Up 0.5% – Here’s What Happened - Defense World
Is Nautilus Biotechnology Inc a good long term investmentEconomic Indicators Overview & Small Budget Portfolio Growth - earlytimes.in
Penny Stocks To Consider In December 2025 - simplywall.st
Investment Report: Will Nautilus Biotechnology Inc. stock attract more institutional investorsEarnings Growth Report & Technical Buy Zone Confirmations - moha.gov.vn
Adversity is less terrifying than hope: Nautilus Biotechnology Inc (NAUT) - setenews.com
Advancing next-generation proteomics with single-molecule Iterative Mapping - SelectScience
There is no way Nautilus Biotechnology Inc (NAUT) can keep these numbers up - Setenews
Advanced analytics toolkit walkthrough for Nautilus Biotechnology Inc.2025 Trading Recap & Precise Trade Entry Recommendations - newser.com
What dividend safety score for Nautilus Biotechnology Inc. stockMarket Growth Report & Low Volatility Stock Recommendations - newser.com
Long term hold vs stop loss in Nautilus Biotechnology Inc.Market Risk Summary & Daily Profit Focused Stock Screening - newser.com
Will Nautilus Biotechnology Inc. stock maintain momentum in 2025Recession Risk & Low Drawdown Investment Ideas - newser.com
Has Nautilus Biotechnology Inc. found a price floorMarket Growth Summary & Free High Accuracy Swing Entry Alerts - newser.com
What candlestick patterns are forming on Nautilus Biotechnology Inc.Weekly Trend Recap & Reliable Price Breakout Signals - newser.com
Will Nautilus Biotechnology Inc. stock outperform value stocksMarket Trend Summary & Reliable Volume Spike Trade Alerts - newser.com
Why Nautilus Biotechnology Inc. stock is recommended by analystsMarket Activity Summary & Risk Controlled Swing Trade Alerts - newser.com
Wall Street Zen Upgrades Nautilus Biotechnology (NASDAQ:NAUT) to Hold - MarketBeat
How to recover losses in Nautilus Biotechnology Inc. stockBull Run & Technical Entry and Exit Alerts - newser.com
Why Nautilus Biotechnology Inc. stock is considered a top pickMarket Sentiment Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Is Nautilus Biotechnology Inc. stock oversold or undervaluedEarnings Overview Summary & Free High Return Stock Watch Alerts - newser.com
How Nautilus Biotechnology Inc. stock performs in rate cut cyclesPortfolio Update Report & Community Trade Idea Sharing Platform - newser.com
Nautilus Biotechnology Inc Azioni (NAUT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Nautilus Biotechnology Inc Azioni (NAUT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Patel Sujal M | CEO, President, and Secretary |
Sep 05 '25 |
Buy |
0.67 |
116,500 |
78,544 |
10,258,221 |
| Patel Sujal M | CEO, President, and Secretary |
Sep 08 '25 |
Buy |
0.68 |
83,500 |
57,031 |
10,341,721 |
| Murphy Matthew B. | General Counsel |
Sep 04 '25 |
Buy |
0.64 |
20,000 |
12,858 |
74,140 |
| Mowry Anna | CFO and Treasurer |
May 29 '25 |
Buy |
0.77 |
15,000 |
11,488 |
83,000 |
| Mallick Parag | Chief Scientist |
May 08 '25 |
Buy |
0.73 |
12,000 |
8,788 |
20,491,892 |
| Mallick Parag | Chief Scientist |
May 12 '25 |
Buy |
0.73 |
1,500 |
1,098 |
20,493,392 |
| Patel Sujal M | CEO, President, and Secretary |
Mar 19 '25 |
Buy |
0.99 |
53,300 |
53,028 |
10,117,788 |
| Patel Sujal M | CEO, President, and Secretary |
Mar 20 '25 |
Buy |
1.00 |
23,933 |
23,890 |
10,141,721 |
0.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):